溶瘤病毒作为多模式癌症治疗的平台：一片充满希望的领域。 - Suppr

Oncolytic viruses as platform for multimodal cancer therapeutics: a promising land.

作者信息

Guo Z S, Bartlett D L

机构信息

Department of Surgery, The University of Pittsburgh Cancer Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

出版信息

Cancer Gene Ther. 2014 Jul;21(7):261-3. doi: 10.1038/cgt.2014.31.

DOI:10.1038/cgt.2014.31

PMID:25034971

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4105137/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2540/4105137/c80a55369f8c/nihms600572f1.jpg

相似文献

Oncolytic viruses as platform for multimodal cancer therapeutics: a promising land.

Cancer Gene Ther. 2014 Jul;21(7):261-3. doi: 10.1038/cgt.2014.31.

Editorial: oncolytic viruses.

Curr Pharm Biotechnol. 2012 Jul;13(9):1731. doi: 10.2174/138920112800958797.

Virotherapy--cancer targeted pharmacology.

Drug Discov Today. 2012 Mar;17(5-6):215-20. doi: 10.1016/j.drudis.2011.12.011. Epub 2011 Dec 16.

Oncolytic viruses in the treatment of cancer: a review of current strategies.

Pathol Oncol Res. 2012 Oct;18(4):771-81. doi: 10.1007/s12253-012-9548-2. Epub 2012 Jun 20.

The fourth front against cancer. The first clinical trials to test engineered viruses that attack tumour cells have yielded promising results for future cancer therapies.

EMBO Rep. 2011 Jul 29;12(8):769-71. doi: 10.1038/embor.2011.138.

Recent clinical experience with oncolytic viruses.

Curr Pharm Biotechnol. 2012 Jul;13(9):1834-41. doi: 10.2174/138920112800958904.

Clinical development of oncolytic viruses in China.

Curr Pharm Biotechnol. 2012 Jul;13(9):1852-7. doi: 10.2174/138920112800958760.

Oncolytic viruses in cancer therapy.

Cancer Lett. 2007 Sep 8;254(2):178-216. doi: 10.1016/j.canlet.2007.02.002. Epub 2007 Mar 23.

Oncolytic viruses: finally delivering.

Br J Cancer. 2016 Feb 16;114(4):357-61. doi: 10.1038/bjc.2015.481. Epub 2016 Jan 14.

Going viral: a review of replication-selective oncolytic adenoviruses.

Oncotarget. 2015 Aug 21;6(24):19976-89. doi: 10.18632/oncotarget.5116.

引用本文的文献

Preclinical and clinical evaluation of intratumoral injection of an IL-12 expressing SKV-012 oncolytic virus for advanced solid tumors.

J Immunother Cancer. 2025 Jun 8;13(6):e011642. doi: 10.1136/jitc-2025-011642.

Viral-Porphyrin Combo: Photodynamic and Oncolytic Viral Therapy for Potent Glioblastoma Treatment.

Int J Mol Sci. 2024 Nov 22;25(23):12578. doi: 10.3390/ijms252312578.

Engineered oncolytic virus expressing B7H3-targeting BiTE enhances antitumor T-cell immune response.

J Immunother Cancer. 2024 Nov 29;12(11):e009901. doi: 10.1136/jitc-2024-009901.

Revolutionizing cancer treatment: the power of bi- and tri-specific T-cell engagers in oncolytic virotherapy.

Front Immunol. 2024 Feb 22;15:1343378. doi: 10.3389/fimmu.2024.1343378. eCollection 2024.

Improving cancer immunotherapy by rationally combining oncolytic virus with modulators targeting key signaling pathways.

Mol Cancer. 2022 Oct 12;21(1):196. doi: 10.1186/s12943-022-01664-z.

Oncolytic immunotherapy for metastatic cancer: lessons and future strategies.

Ann Transl Med. 2020 Sep;8(17):1113. doi: 10.21037/atm.2020.04.42.

Efficient Delivery and Replication of Oncolytic Virus for Successful Treatment of Head and Neck Cancer.

Int J Mol Sci. 2020 Sep 25;21(19):7073. doi: 10.3390/ijms21197073.

Bi- and Tri-Specific T Cell Engager-Armed Oncolytic Viruses: Next-Generation Cancer Immunotherapy.

Biomedicines. 2020 Jul 10;8(7):204. doi: 10.3390/biomedicines8070204.

IL-24-Armed Oncolytic Vaccinia Virus Exerts Potent Antitumor Effects via Multiple Pathways in Colorectal Cancer.

Oncol Res. 2021 Mar 16;28(6):579-590. doi: 10.3727/096504020X15942028641011. Epub 2020 Jul 8.

Curcumin Enhances the Antitumoral Effect Induced by the Recombinant Vaccinia Neu Vaccine (rV-T) in Mice with Transplanted Salivary Gland Carcinoma Cells.

Nutrients. 2020 May 14;12(5):1417. doi: 10.3390/nu12051417.

本文引用的文献

Oncolytic Immunotherapy: Dying the Right Way is a Key to Eliciting Potent Antitumor Immunity.

Front Oncol. 2014 Apr 10;4:74. doi: 10.3389/fonc.2014.00074. eCollection 2014.

Combining oncolytic HSV-1 with immunogenic cell death-inducing drug mitoxantrone breaks cancer immune tolerance and improves therapeutic efficacy.

Cancer Immunol Res. 2013 Nov;1(5):309-19. doi: 10.1158/2326-6066.CIR-13-0059-T. Epub 2013 Aug 19.

Oncolytic viruses and their application to cancer immunotherapy.

Cancer Immunol Res. 2014 Apr;2(4):295-300. doi: 10.1158/2326-6066.CIR-14-0015.

Targeting gallbladder cancer: oncolytic virotherapy with myxoma virus is enhanced by rapamycin in vitro and further improved by hyaluronan in vivo.

Mol Cancer. 2014 Apr 13;13:82. doi: 10.1186/1476-4598-13-82.

Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy.

Sci Transl Med. 2014 Mar 5;6(226):226ra32. doi: 10.1126/scitranslmed.3008095.

Complementary induction of immunogenic cell death by oncolytic parvovirus H-1PV and gemcitabine in pancreatic cancer.

J Virol. 2014 May;88(10):5263-76. doi: 10.1128/JVI.03688-13. Epub 2014 Feb 26.

Smac mimetics and innate immune stimuli synergize to promote tumor death.

Nat Biotechnol. 2014 Feb;32(2):182-90. doi: 10.1038/nbt.2806. Epub 2014 Jan 26.

T-cell engager-armed oncolytic vaccinia virus significantly enhances antitumor therapy.

Mol Ther. 2014 Jan;22(1):102-11. doi: 10.1038/mt.2013.240. Epub 2013 Oct 17.

Oncolytic viruses as therapeutic cancer vaccines.

Mol Cancer. 2013 Sep 11;12(1):103. doi: 10.1186/1476-4598-12-103.

Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in (V600D/E)BRAF mutant melanoma depends on JNK and TNF-α signaling.

Oncogene. 2014 Mar 27;33(13):1700-12. doi: 10.1038/onc.2013.112. Epub 2013 Apr 29.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Oncolytic viruses as platform for multimodal cancer therapeutics: a promising land.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献